866-997-4948(US-Canada Toll Free)

Nanotechnology for Medical Diagnostics

Published By :

Cientifica

Published Date : Mar 2012

Category :

Nanotechnology

No. of Pages : 236 Pages


Following on from our “Nanotechnology for Drug Delivery” series of reports we are turning the focus onto medical diagnostics with our latest report: “Nanotechnology for Medical Diagnostics” Nanotech enabled medical diagnostics promise to improve just about everything that can be improved from a diagnostics point of view: earlier detection of disease, higher sensitivity, higher accuracy, higher throughput capability, more results per assay; time saving and cost-effectiveness.

As with our “Nanotechnology for Drug Delivery” series of reports, this report provides a market numbers for the nanotech enabled medical diagnostic market between 2000-2010 and a market forecast for the period 2011-2021. 

Report Scope Two sets of data are presented in this report:
  • The TAM growth for NMBD between 2000-2010;
  • TAM forecast for NMBD between 2011- 2021.
  • Both sets of data are segmented into;

TAM (US$ millions, % share, and CAGR) for:
  • America Asia (key economies) Europe (key economies) RoW (key economies)
  • Technology type (US$ millions, % share and CAGR) for;

Main Technological Approaches:
  • Quantum dots (QDs);
  • Gold nanoparticles;
  • Cantilevers;
  • Exosomes;
  • Nanobiosensors;
  • Main Technological Applications:
  • Nanotechnology-based medical and biomedical imaging for diagnostics;
  • Nanotechnology-based medical devices for diagnostics;
  • Nanotechnology in Early Disease Detection. 

Geographical ScopeThe studied regions are:

  • North America:
  • USA;
  • European Union (27):
  • Germany;
  • France;
  • UK;
  • Other Countries of EU;
Russian Federation

  • Asia:
  • India;
  • Japan;
  • P. R. China;
  • South Korea (R. of Korea);
  • Taiwan;
RoW Quantifying the Total Addressable Market (TAM) CurrentThe TAM for nanotech enabled diagnostics is estimated to be 2.439 US$ Billion (end of 2011).

Nanotechnology applied to medical imaging and gold nanoparticles for diagnosis were the application and technology respectively, with the highest growth during the last decade, currently (2011 figures) at:
  • Medical Imaging: 1.7 Billion US$
  • Gold Nanoparticles: 959 Million US$
While the US, China and Germany were the countries with the highest growth currently (2011 figures) at:
  • North America: 675 Million US$
  • China: 330 Million US$
  • Germany: 117 Million US$

Forecast

We forecast the TAM for nanotech enabled diagnostics to reach $53.6B in 2021. In comparison our report “Nanotechnology for Drug Delivery” forecasts a TAM of $136B in 2021 for nanotech enabled drug delivery.

In 2021, Asia (China, Japan, South Korea, Taiwan, India combined) tops the list with the highest TAM, China and India are neck and neck for CAGR. Of all the technologies studied for this report, exosomes for diagnosis show the highest CAGR between 2011-2021 while medical imaging remains the highest growth application of the nanotech enabled diagnostics market in 2021.
Table of Content

TABLE OF EXHIBITS

Chapter One

Chapter Two

Chapter Three

Chapter Four
Appendix
Executive Summary

CHAPTER 1 INTRODUCTION AND METHODOLOGY
Report Scope
Scope of Data Analysis
Thematic Scope
Geographical Scope
Methodology
Procurement
Calculation of CAGR
The Nanoscale
Two biological examples that illustrate nanoscale:

CHAPTER 2 INTRODUCTION TO NANOTECHNOLOGY & MEDICINE - OVERVIEW OF NANOTECHNOLOGY
Why is Nanotechnology A Critical Application for Medicine and Biomedicine?
Why Nanotechnology Is Needed for Medicine and Biomedicine?

WHAT ARE THE KEY DRIVERS FOR ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE?
The Aim Of Targeting For Detection, Quantification And Characterization Purposes –
Molecular Recognition in Nanotechnology in Medical And Biomedical Diagnostics
Reasons Why The Market of Nanotechnology in Medical And Biomedical Diagnostics
Expanded so Rapidly During The 2000-2010 Decade
Market Drivers For Nanotechnology-Based Medical And Biomedical Diagnostics
Reasons Why The Market of Nanotechnology in Medical And Biomedical Diagnostics Will
Rapidly Expand
Drivers For Synergies Between Nanotechnology in Medical And Biomedical Diagnostics
And Nanotechnology in Drug Delivery
Increasing Proportion of The Ageing Population
Demand For More Affordable Health Care
Public Health – Ending disease
Demand For More Innovation
Social Responsibility

THE MOST IMPORTANT FIELDS IN THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
Nanotechnology in Drug Delivery
Nanotechnology for Medical Diagnostics
Nanotechnology in Regenerative Medicine and Tissue Engineering
Other Applications For Nanomaterials In The Medical And Pharmaceutical Sector

HOW NANOTECHNOLOGY IS ALREADY HAVING AN IMPACT IN MEDICAL AND BIOMEDICAL DIAGNOSTICS
Case Study 1 – Diagnosis of head-and-neck cancer from exhaled breath
Case Study 2 – UTSA researchers embracing nanotechnology to accelerate diagnostics
Case Study 3 – Biocompatible graphene transistor array reads and records action potentials from electrogenic cells

CHAPTER 3 KEY BARRIERS TO THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
Nanotoxicity Nanopollution and Nanosafety
Ethical Considerations of Nanotherapies
Delayed Nanoregulation

CURRENT & FUTURE CHALLENGES IN THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
Current & Future Challenges of Nanosafety And Risk Management
Current & Future Challenges of Nanoregulation
Current & Future Challenges of Nanomedicine Industry
Current & Future Challenges of Sustained Innovation
Current & Future Challenges of Cooperation

TAM ANALYSIS, WITHOUT SEGMENTATION (2000-2010)

TAM FORECAST , WITHOUT SEGMENTATION (2011-2021)

CHAPTER 4 OVERVIEW OF THE KEY NANOTECHNOLOGIES USED IN MEDICAL AND BIOMEDICAL DIAGNOSTICS SORTED BY APPLICATIONS
Nanotechnology in Medical and Biomedical Diagnostics: Diagnostics Nanotechnologies
Quantum Dots
Preparing Quantum Dots
Operation of Quantum Dots
Detection of Quantum Dots
Features And Benefits of Quantum Dots
Disadvantages of Quantum Dots
Application of Quantum Dots to Medical And Biomedical Nanotechnology-Based
Diagnostics Assays
Prostate-specific antigen assay
Acetylcholine assay
Targeting of membrane protein P-glycoprotein (Pgp) in HeLa cells that had been transiently transfected by a plasmid encoding for Pgp
Cellular organelles assay
Cancer detection assay
Imaging assays
Gold Nanoparticles
Application of Gold nanoparticles to Medical And Biomedical Diagnostics Assays
PSA assay
Alzheimer’s disease BCA
BCA as a possible alternative for PCR
Cantilevers
Application of Cantilevers to Medical And Biomedical Diagnostics Assays
Exosomes
Nanotechnology for Medical Diagnostics
Microvesicles Overview
Microvesicles as Mediators of Intercellular Communication
Types of Released Microvesicles
Intracellular Origin of Exosomes
Exosomes as Nanotechnology in medical and biomedical diagnostics Biomarkers
Nanobiosensors
Medical and Biomedical Imaging
Fluorescent Nanoparticles
In vivo nanoparticle-based near-infrared fluorescence (NIRF) imaging techniques
Nanobioimaging
Nanotechnology-Based Medical Devices For Diagnostic
Nanopatterned Medical Devices for Diagnostic
Nanoporous Silica Nanochips
Nanowire Biosensors
Micro- And Nanocantilever Arrays
Molecularly Gated Single Electron Transistors
The Most Relevant Technologies in The Key Area of Nanotechnology in Medical And
Biomedical Diagnostics

STAGE OF DEVELOPMENT OF KEY NANOTECHNOLOGIES USED IN MEDICAL AND BIOMEDICAL DIAGNOSTICS
Genomics and Proteomics in Nanotechnology in Medical and Biomedical Diagnosis in a Context of Personalized Medicine
The Potential of The Adoption of Nanotechnology to Medical And Biomedical
Diagnostics

TAM ANALYSIS, WITH SEGMENTATION (2000-2010)
TAM by Country
TAM by Key Technology

TECHNOLOGY ADOPTION ROADMAP
Projected Product Pipeline For Nanotechnology-Based Medical and Biomedical
Diagnostics Market
Projected Product Pipeline For Nanotechnology-Based Medical Devices For Medical And
Biomedical Diagnostics
Projected Product Pipeline For Nanotechnology-Based Medical Devices For Theranostics
Projected Product Pipeline For Nanotechnology-Based Medical Imaging For Medical And
Biomedical Diagnostics

TAM FORECAST, WITH SEGMENTATION (2011- 2021)
TAM Forecast by Country
TAM forecast by Key Technology

SWOT ANALYSIS (2011-2021 PERIOD)
APPENDIX
Publishing activity by organization (2000-2010)

List of Table


CHAPTER ONE
Exhibit 1.1
Formula for the calculation of the Compound Annual Growth Rate (CAGR) [2].
Exhibit 1.2
Formula for the verification of the calculated values of CAGR (2011-2021) [2].
Exhibit 1.3
Metres in a nanometre (top), nanometres in a metre (bottom)
CHAPTER TWO
Exhibit 2.1
Illustration of the fact that the periodic table of elements, as we know it (at meter scale)governed by classic Newtonian laws of physics. However, when perceived at nanoscale,those elements are governed by the laws of quantum physics.
Exhibit 2.2
Proportion of the population aged over 65 and over 80 [8].
CHAPTER THREE
Exhibit 3.1
Key barriers to the adoption of nanotechnology in medicine and biomedicine (Source: Cientifica, Ltd.).
Exhibit 3.2
Specified expected barriers in the development of particular types of nanoparticles (Courtesy of CienNanoroadmap Synthesis Report), [6].
Exhibit 3.3
Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, without segmentation, source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.4
Line chart representing Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, without segmentation, source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.5
Bar chart representing Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, without segmentation, source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.6
Table representing the Total Addressable Market, TAM forecast to 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, without segmentation, source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.7
Line chart representing the Total Addressable Market, TAM forecast to 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, without segmentation, source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.8
Bar chart representing the Total Addressable Market, TAM forecast to 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, without segmentation, source: Cientifica (all figures US$ Million Dollars).
CHAPTER FOUR
Exhibit 4.1
Summarized comparison of characteristics of quantum dots (QDs), cantilevers and gold nanoparticles in the scope of the adoption of nanotechnology to clinical diagnosis [3].
Exhibit 4.2
Schematic diagram representing the general structure of a Quantum dot (in this case, a typical CdSe/ZnS QD). The coating extremities can change according to requirements regarding application and biocompatibility (e.g. mercaptoacetic acid or streptavidin) [3].
Exhibit 4.3
A schematic diagram of a multiplex QD-based assay. Multiple antigens (Ag) can be labelled through the use of primary antibodies (Ab) conjugated to QDs with different sizes. One antibody may be biotinylated and detected with a streptavidin-coated QD. On excitation, QDs will have different emission maxima based on their sizes [3].
Exhibit 4.4
A summary of toxicity breakthroughs standing on selected quantum dots studies [3].
Exhibit 4.5
Selected examples of quantum dots-based assays. The presented quantum dots have different recognition moieties [3].
Exhibit 4.6
Examples of the adoption of nanotechnology to medical and biomedical diagnosis and a summary of the characteristics of those technologies [3].
Exhibit 4.7
Schematic representation of production and release of exosomes. The exocytic multivesicular bodies may fuse with membrane and release exosomes [4].
Exhibit 4.8
Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, all countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.9
3-D pie chart representing the Total Addressable Market, TAM in 2010, for
nanotechnology in medical and biomedical diagnostics, by world regions and countries, source: Cientifica (all figures in percentage).
Exhibit 4.10
Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.11
Line chart representing the Total Addressable Market, TAM (2000-2010), for
nanotechnology in medical and biomedical diagnostics, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.12
3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.13
3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.14
3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, all world regions and countries studied, source: Cientifica (all figures in percentage).
Exhibit 4.15
Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, all world regions and countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.16
3-D pie chart representing the Total Addressable Market, TAM in 2010, for
nanotechnology in medical and biomedical diagnostics, European Union countries studied, source: Cientifica (all figures in percentage).
Exhibit 4.17
Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.18
Line chart representing the Total Addressable Market, TAM (2000-2010), for
nanotechnology in medical and biomedical diagnostics, European Union countries studied,
source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.19
3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.20
3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, European Union countries studied,source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.21
3-D pie chart representing the Total Addressable Market, TAM in 2010, for
nanotechnology in medical and biomedical diagnostics, Asian countries studied, source:Cientifica (all figures in percentage).
Exhibit 4.22
Horizontal bar graph representing the Total Addressable Market, TAM In 2010, for nanotechnology in medical and biomedical diagnostics, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.23
Line chart representing the Total Addressable Market, TAM (2000-2010), for
nanotechnology in medical and biomedical diagnostics, Asian countries studied, source:Cientifica (all figures US$ Million Dollars).
Exhibit 4.24
3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, Asian countries studied,source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.25
3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, Asian countries studied, source:Cientifica (all figures US$ Million Dollars).
Exhibit 4.26
Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, all most relevant key technologies, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.27
3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures in percentage).
Exhibit 4.28
Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.29
Line chart representing the Total Addressable Market, TAM (2000-2010), for
nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.30
3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010) , for nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.31
3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010) , for nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.32
3-D pie chart representing the Total Addressable Market, TAM in 2010, for
nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures in percentage).
Exhibit 4.33
Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.34
Line chart representing the Total Addressable Market, TAM (2000-2010), for
nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.35
3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010) , for nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.36
3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010) , for nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.37
3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures in percentage).
Exhibit 4.38
Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.39
Line chart representing the Total Addressable Market, TAM (2000-2010), for
nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.40
3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010) , for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.41
3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010) , for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.42
3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures in percentage).
Exhibit 4.43
Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.44
Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, impact of early disease detection,source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.45
3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010) , for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.46
3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010) , for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.47
Table representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, by world regions / countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.48
3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, by world regions, source: Cientifica (all figures in percentage).
Exhibit 4.49
Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021,for nanotechnology in medical and biomedical diagnostics, by world regions, source:Cientifica (all figures US$ Million Dollars).
Exhibit 4.50
Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, by world regions, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.51
3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, by world regions, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.52
3-D stacked area chart representing the Total Addressable Market, TAM forecast by (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, by world regions, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.53
3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, by all world regions / countriesstudied, source: Cientifica (all figures in percentage).
Exhibit 4.54
Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021,for nanotechnology in medical and biomedical diagnostics, by all world regions / countriesstudied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.55
Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the2011-2021 period), for nanotechnology in medical and biomedical diagnostics, by all worldregions / countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.56
3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecastby 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedicaldiagnostics, by all world regions / countries studied, source: Cientifica (all figures US$Million Dollars).
Exhibit 4.57
3-D stacked area chart representing the Total Addressable Market, TAM forecast by (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, byall world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.58
3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, fornanotechnology in medical and biomedical diagnostics, European Union countries studied,source: Cientifica (all figures in percentage).
Exhibit 4.59
Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021,for nanotechnology in medical and biomedical diagnostics, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.60
Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the2011-2021 period), for nanotechnology in medical and biomedical diagnostics, EuropeanUnion countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.61
3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecastby 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedicaldiagnostics, European Union countries studied, source: Cientifica (all figures US$ MillionDollars).
Exhibit 4.62
3-D stacked area chart representing the Total Addressable Market, TAM forecast by (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics,European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.63
3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, Asian countries studied, source: Cientifica (all figures in percentage).
Exhibit 4.64
Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.65
Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the2011-2021 period), for nanotechnology in medical and biomedical diagnostics, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.66
3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecastby 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedicaldiagnostics, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.67
3-D stacked area chart representing the Total Addressable Market, TAM forecast by (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics,Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.68
Table representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, all most relevant key technologies, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.69
3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, fornanotechnology in medical and biomedical diagnostics, all key technologies studied, source:Cientifica (all figures in percentage).
Exhibit 4.70
Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021,for nanotechnology in medical and biomedical diagnostics, all key technologies studied,source: Cientifica (all figures in percentage).
Exhibit 4.71
Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the2011-2021 period), for nanotechnology in medical and biomedical diagnostics, all keytechnologies studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.72
3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecastby 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedicaldiagnostics, all key technologies studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.73
3-D stacked area chart representing the Total Addressable Market, TAM forecast by (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, allkey technologies studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.74
3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, fornanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures in percentage).
Exhibit 4.75
Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021,for nanotechnology in medical and biomedical diagnostics, technological approaches as awhole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.76
Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the2011-2021 period), for nanotechnology in medical and biomedical diagnostics,technological approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.77
3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecastby 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedicaldiagnostics, technological approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.78
3-D stacked area chart representing the Total Addressable Market, TAM forecast by (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics,technological approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.79
3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, fornanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures in percentage).
Exhibit 4.80
Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021,for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.81
Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.82
3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.83
3-D stacked area chart representing the Total Addressable Market, TAM forecast by (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics,technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.84
3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures in percentage).
Exhibit 4.85
Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.86
Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.87
3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecastby 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedicaldiagnostics, impact of early disease detection, source: Cientifica (all figures US$ MillionDollars).
Exhibit 4.88
3-D stacked area chart representing the Total Addressable Market, TAM forecast by (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics,impact of early disease detection, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.89
SWOT analysis to evaluate the strengths, weaknesses, opportunities and threats involved innanotechnology in medical and biomedical diagnostics, in the scope of the technologyadoption roadmap (during the 2011-2021 period).
APPENDIX
Exhibit A.1
Table of the top 20 organizations showing the highest publishing activity in PubMedperiodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. WorldRegion: North America; country: USA.Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.2
Table of the top 20 organizations showing the highest publishing activity in PubMedperiodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. WorldRegion: European Union; country: Germany.Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.3
Table of the top 20 organizations showing the highest publishing activity in PubMedperiodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. WorldRegion: European Union; country: France.Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.4
Table of the top 20 organizations showing the highest publishing activity in PubMedperiodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: UK.
Exhibit A.5
Table of the organizations with publishing activity in PubMed periodicals (2000-2010),based on PubMed, for Nanotechnology in Drug Delivery. Country: Russian Federation.Organizations are ordered alphabetically (increasing order).
Exhibit A.6
Table of the top 20 organizations showing the highest publishing activity in PubMedperiodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. WorldRegion: Asia; country: India.Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.7
Table of the top 20 organizations showing the highest publishing activity in PubMedperiodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. WorldRegion: Asia; country: India.Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.8
Table of the top 20 organizations showing the highest publishing activity in PubMedperiodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. WorldRegion: Asia; country: Japan.Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.9
Table of the top 20 organizations showing the highest publishing activity in Pub Med periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. WorldRegion: Asia; country: P R China.Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.10
Table of the top 20 organizations showing the highest publishing activity in Pub Med periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. WorldRegion: Asia; country: South Korea (Republic of Korea).Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.11
Table of the organizations with publishing activity in PubMed periodicals (2000-2010),based on PubMed, for Nanotechnology in Drug Delivery. Asia; country: Taiwan.

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *